Japan Pharmacy Market

ID: MRFR/MED/50764-HCR 200 Pages Nidhi Mandole Last Updated: September 17, 2026
Japan Pharmacy Market Research Report: Size, Share, Trend Analysis By Product Type (Prescription Drugs, Over-The-Counter Drugs, Vaccines, Homeopathic Medicine), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy, Specialty Pharmacy), By Therapeutic Area (Cardiovascular, Oncology, Diabetes, Neurology, Infectious Diseases) and By Formulation (Tablets, Injectables, Topicals, Liquids) - Growth Outlook & Industry Forecast 2025 To 2035
Japan Pharmacy Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.06%
2024 Market Size$ 33.5 Billion
2025 Market Size$ 35.53 Billion
2035 Market Size$ 64 Billion
Key Players
CVS Health
Walgreens Boots Alliance
UnitedHealth Group
Cigna
Roche
Novartis
Trends
  • Digital Health Integration
  • Aging Population Impact
  • Regulatory Changes and Competition
Opportunities
  • Rising Demand for Personalized Medicine
  • Increased Focus on Preventive Healthcare
  • Expansion of E-commerce in Pharmaceutical Sales
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Industrial Automation & Equipment, BY Product Type (USD Billion)
      1. 4.1.1 Prescription Drugs
      2. 4.1.2 Over-The-Counter Drugs
      3. 4.1.3 Vaccines
      4. 4.1.4 Homeopathic Medicine
    2. 4.2 Industrial Automation & Equipment, BY Distribution Channel (USD Billion)
      1. 4.2.1 Retail Pharmacy
      2. 4.2.2 Hospital Pharmacy
      3. 4.2.3 Online Pharmacy
      4. 4.2.4 Specialty Pharmacy
    3. 4.3 Industrial Automation & Equipment, BY Therapeutic Area (USD Billion)
      1. 4.3.1 Cardiovascular
      2. 4.3.2 Oncology
      3. 4.3.3 Diabetes
      4. 4.3.4 Neurology
      5. 4.3.5 Infectious Diseases
    4. 4.4 Industrial Automation & Equipment, BY Formulation (USD Billion)
      1. 4.4.1 Tablets
      2. 4.4.2 Injectables
      3. 4.4.3 Topicals
      4. 4.4.4 Liquids
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 CVS Health (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Walgreens Boots Alliance (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 UnitedHealth Group (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cigna (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Roche (CH)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Novartis (CH)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Sanofi (FR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 AstraZeneca (GB)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Bayer (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    4. 6.4 JAPAN MARKET ANALYSIS BY THERAPEUTIC AREA
    5. 6.5 JAPAN MARKET ANALYSIS BY FORMULATION
    6. 6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
    9. 6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    11. 6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
    12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY THERAPEUTIC AREA, 2024 (% SHARE)
    17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
    18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY FORMULATION, 2024 (% SHARE)
    19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY FORMULATION, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
      4. 7.2.4 BY FORMULATION, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Japan Pharmacy Market Segmentation

Japan Pharmacy Market By Product Type (USD Billion, 2025-2035)

  • Prescription Drugs
  • Over-The-Counter Drugs
  • Vaccines
  • Homeopathic Medicine

Japan Pharmacy Market By Distribution Channel (USD Billion, 2025-2035)

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • Specialty Pharmacy

Japan Pharmacy Market By Therapeutic Area (USD Billion, 2025-2035)

  • Cardiovascular
  • Oncology
  • Diabetes
  • Neurology
  • Infectious Diseases

Japan Pharmacy Market By Formulation (USD Billion, 2025-2035)

  • Tablets
  • Injectables
  • Topicals
  • Liquids

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.